A 15-year-old girl with normal renal function took 75 tablets of allopurinol 300 mg. She did not suffer any ill-effects. Samples obtained over 84 h showed prolonged elimination of allopurinol, with a half-life of 3.6 h, and oxipurinol, with a half-life of 26 h.
Get full access to this article
View all access options for this article.
References
1.
Simmonds HA & Cameron JSUse and abuse of allopurinol. British Medical Journal1987; 294: 1504-5.
2.
Simmonds HA, Cameron JS, Morris GS & Davies PMAllopurinol in renal failure and the tumour lysis syndrome. Clinica Chimica Acta1986; 160: 189-95.
3.
Morris GS & Simmonds HAUse of a fundamental elution protocol for the development of a reverse phase HPLC method enabling rapid simultaneous determination of purines, pyrimidines and allied compounds commonly found in biological fluids. Journal of Chromatography1985:344: 101-33.
4.
Hande K., Reed E. & Chabner B.Allopurinol kinetics. Clinical Pharmacology and Therapeutics1978; 23: 598-605.
5.
Elion GB, Benezra FM, Beardmore TD & Kelley WNStudies with allopurinol in patients with impaired renal function. Advances in Experimental Medicine and Biology1980; 122A: 263-7.
